Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Well Care Compounding Pharmacy is recalling Vancomycin 50mg/mL ophthalmic solution due to FDA inspection findings of GMP violations that may impact sterility.
Well Care Compounding Pharmacy is recalling Methylcobalamin 5mg/mL vials because FDA inspections found GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling M.l.C./B5/B6 injection vials due to FDA inspection findings of GMP violations that may impact sterility.
Well Care Compounding Pharmacy is recalling compounded L-Glutamine/L-Arginine/L-Carnitine injections due to FDA inspection findings regarding sterility assurance.
Well Care Compounding Pharmacy is recalling QUAD-MIX #4 (MOD) vials because FDA inspections found violations that may affect product sterility.
Well Care Compounding Pharmacy is recalling M.I.C. /MB12/B6/DEXPLAN/L-CARN injection vials because FDA inspections found GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Itraconazole/Mupirocin/Triamcinolone nasal spray because FDA inspections found GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Testosterone Cypionate 200mg/mL vials because FDA inspections found GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Testosterone Cypionate 10mg/mL vials because FDA inspections found GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Alpha Lipoic Acid 25mg/mL vials due to FDA inspection findings of GMP violations that may impact sterility.
Well Care Compounding Pharmacy is recalling Estradiol Cypionate 10 mg/mL vials because FDA inspections found GMP violations that may affect sterility.
Novo Nordisk is recalling 723 Norditropin FlexPro pens due to a potential assembly fault that may cause the pen to block during the air shot step.
Well Care Compounding Pharmacy is recalling TRI-MIX # 2 vials because FDA inspections found violations that may affect sterility.
Well Care Compounding Pharmacy is recalling M.l.C. 25mg/50mg/25mg/mL vials because FDA inspections found GMP violations that may affect sterility.
Aidarex Pharmaceuticals is recalling 292 bottles of Chlorhexidine Gluconate 0.12% Oral Rinse because the product failed impurity specifications.
Well Care Compounding Pharmacy is recalling 869 units of Hydrogen Peroxide 3% due to FDA inspection findings regarding sterility assurance.
Well Care Compounding Pharmacy is recalling 1-HCG 2000 IU/ML vials due to GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Phenylephrine 0.5% vials because FDA inspections found violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Atropine Sulfate 0.5% Ophthalmic Drops due to FDA inspection findings of GMP violations that may impact sterility.
Pharmedium Services is recalling 240 bags of Potassium Chloride Injection due to a labeling error where Potassium Phosphate was printed on the label stock.
Well Care Compounding Pharmacy is recalling TRI-MIX # 6 vials because FDA inspections found violations that may affect product sterility.
Bayer Health Care LLC is recalling 37,512 bottles of Coppertone Sunscreen Lotion, Clearly Sheer, Broad Spectrum SPF 50, because the product contains undeclared Oxybenzone.
Well Care Compounding Pharmacy is recalling 869 vials of Methylcobalamin 12.5mg/mL due to FDA inspection findings of GMP violations that may impact sterility.
Aidarex Pharmaceuticals is recalling Ceftriaxone for Injection due to out-of-specification intermediates during manufacturing.
Akorn, Inc. is recalling specific lots of Sulfacetamide Sodium Ophthalmic Solution because they failed antimicrobial effectiveness testing, raising concerns about sterility.